FASN and urinary bladder carcinoma: Collectively, this study demonstrates that P. distasonis‐derived 3‐IAA can inhibit bladder cancer metastasis and proliferation, highlighting the AhR‐FASN axis as a promising therapeutic target to inhibit bladder cancer progression.